Vi anvender cookies på vores website for at forbedre din brugeroplevelse.Læs mere
Dr Daniel Shelly at Albumedix talks to EBR about how cell therapy is at a turning point, driven by advances in the recognition of the sector’s nature, and how albumin can be used for cell culture, formulation and cryopreservation.
Published April 14th 2018 in European Biopharmaceutical Review: http://www.samedanltd.com/magazine/current/12
Article available in PDF: HERE
Read more about albumin in cell therapy HERE